Prime Movers Lab Fund I LP's Form 4 filing
Vaxxinity, Inc. (VAXX) · filed Jan 25, 2023
- Accession no.
- 0001062993-23-001392
- Filed
- Jan 25, 2023, 5:58 PM ET
- Trade date
- Jan 23, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.68M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prime Movers Lab Fund I LPCIK 0001751631 | 10% Owner |
| Sloss DakinCIK 0001875411 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price of $3.3514 per share represents a weighted average of purchase prices ranging from $3.19 to $3.62 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 2 transactions in Table I.